Science ❯ Biotechnology ❯ RNA Interference ❯ Drug Development

Clinical Trials

Biotech Veterans Launch Corsera Health to Develop a Once‑Yearly RNAi Heart Prevention Shot

The startup pairs a dual‑target siRNA therapy with an AI risk model to identify candidates for early intervention.